TARDOC Reimbursement Unlocks Major Outpatient Market Opportunity for the LiMAx® Test in Switzerland
LiMAx - quantifying functional liver capacity
With Switzerland becoming the first country to enable full outpatient reimbursement for LiMAx®, Humedics gains a strategic foothold for broader European market penetration.
A Scalable Outpatient Revenue Model Now Enabled
An independent economic analysis commissioned by Humedics confirms that the LiMAx® test is reimbursable under TARDOC at approximately €970 per test, including all associated medical services. Under the previous tariff system, outpatient deployment was economically unattractive or not viable. The shift to a cost‑covering tariff fundamentally changes the commercial dynamics:
• Outpatient use becomes financially viable and predictable
• Hospitals, specialist clinics, and private practices gain investment security
• A new high‑volume, decentralized market segment opens for LiMAx®
The reimbursement clarity and economic stability of TARDOC lay the foundation for scalable adoption in both established liver centers and emerging outpatient providers.
Strong Strategic Advantages for Providers and Payers
The TARDOC reimbursement framework enables healthcare providers to integrate LiMAx® more widely into routine care, driven by clear economic and clinical advantages:
• Transparent and adequate remuneration aligned with actual resource use
• Optimized resource allocation through targeted use of advanced diagnostics
• Reduction of complications and downstream treatment costs
• Support for outpatient care models, relieving inpatient budgets
• Improved financial predictability for providers offering innovative diagnostics
Precise assessment of liver function enables earlier and better‑informed clinical decisions in surgery, oncology, hepatology, and pharmacotherapy – directly improving patient pathways and reducing avoidable expenses.
LiMAx®: A Clinically Proven Technology with Strong Economic Impact
The LiMAx® (Liver Maximum Capacity) test is the only non‑invasive diagnostic that measures dynamic liver function quantitatively in real time. Its ability to support surgical planning, and improve risk stratification creates a clear medical and economic value proposition. By enabling better treatment decisions early in the care pathway, LiMAx® supports:
• Avoidance of post‑operative complications
• Reduction of length of stay
• Prevention of ineffective treatment strategies
• More efficient resource utilization across care settings
This positions LiMAx® as a high‑value diagnostic tool in modern, value‑based healthcare systems.
TARDOC as a Catalyst for Innovation and Market Expansion
Approved by the Swiss Federal Council in April 2025, TARDOC replaces the outdated TARMED system and introduces a modern reimbursement structure that reflects complexity, time, and real resource consumption. For Humedics, this regulatory advancement is a commercial acceleration trigger, enabling rapid outpatient scaling across Switzerland and providing a replicable model for other European healthcare systems.
“The implementation of TARDOC is a turning point for Humedics and for the adoption of the LiMAx® test. For the first time, outpatient providers in Switzerland can deploy LiMAx® with full and predictable reimbursement, unlocking a significant new market segment. This milestone strengthens our commercial trajectory, accelerates our expansion strategy, and confirms the growing recognition of functional liver diagnostics in modern healthcare. With Switzerland leading the way, we expect further momentum as other European systems move toward similar reimbursement frameworks,” stated Dr. Chalom Sayada, Chief Executive Officer, Humedics
About Humedics
Humedics develops and commercializes the LiMAx® test, the first real‑time quantitative liver function diagnostic, enabling precise clinical decision‑making in surgery, hepatology, oncology, and supporting drug therapy management.
Alexander Helmke
Humedics GmbH
+49 30 62939550
info@humedics.de
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
